Modeling Substrate Entry into the P-Glycoprotein Efflux Pump at the Blood-Brain Barrier

被引:3
|
作者
Jorgensen, Christian [1 ,2 ]
Ulmschneider, Martin B. [3 ]
Searson, Peter C. [1 ,4 ]
机构
[1] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA
[2] Aarhus Univ, Langelandsgade 140, DK-8000 Aarhus, Denmark
[3] Kings Coll London, Dept Chem, London SE1 1DB, England
[4] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
基金
美国国家卫生研究院;
关键词
MOLECULAR-DYNAMICS SIMULATIONS; ATP HYDROLYSIS; MULTIDRUG-RESISTANCE; LATERAL DIFFUSION; PLASMA-MEMBRANE; BINDING; NUCLEOTIDE; TRANSPORT; REVEAL; RHODAMINE-123;
D O I
10.1021/acs.jmedchem.3c01069
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report molecular dynamics simulations of rhodamine entry into the central binding cavity of P-gp in the inward open conformation. Rhodamine can enter the inner volume via passive transport across the luminal membrane or lateral diffusion in the lipid bilayer. Entry into the inner volume is determined by the aperture angle at the apex of the protein, with a critical angle of 27(degrees )for rhodamine. The central binding cavity has an aqueous phase with a few lipids, which significantly reduces substrate diffusion. Within the central binding cavity, we identified regions with relatively weak binding, suggesting that the combination of reduced mobility and weak substrate binding confines rhodamine to enable the completion of the efflux cycle. Tariquidar, a P-gp inhibitor, aggregates at the lower arms of the P-gp, suggesting that inhibition involves steric hindrance of entry into the inner volume and/or steric hindrance of access of ATP to the nucleotide-binding domains.
引用
收藏
页码:16615 / 16627
页数:13
相关论文
共 50 条
  • [21] Pharmacokinetics of P-Glycoprotein Inhibition in the Rat Blood-Brain Barrier
    Syvanen, Stina
    Hooker, Andrew
    Rahman, Obaidur
    Wilking, Helena
    Blomquist, Gunnar
    Langstrom, Bengt
    Bergstrom, Mats
    Hammarlund-Udenaes, Margareta
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (12) : 5386 - 5400
  • [22] P-glycoprotein regulated transport of glutamate at blood-brain barrier
    Liu, XD
    Liu, GQ
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (02): : 111 - 116
  • [23] P-glycoprotein in the blood-brain barrier versus sensitivity to ivermectin
    Skipor, J
    Thiery, JC
    MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2005, 61 (04): : 384 - 386
  • [24] Corticosteroid Regulation of P-Glycoprotein in the Developing Blood-Brain Barrier
    Iqbal, Majid
    Gibb, William
    Matthews, Stephen G.
    ENDOCRINOLOGY, 2011, 152 (03) : 1067 - 1079
  • [25] Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
    Bartels, A. L.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (26) : 2771 - 2777
  • [26] P-glycoprotein function in the blood-brain barrier of epileptic rats
    Syvanen, S.
    Luurtsema, G.
    Molthoff, C. F. M.
    Windhorst, A. D.
    Huisman, M. C.
    Lammertsma, A. A.
    Voskuyl, R. A.
    de lange, E. C. M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S209 - S209
  • [27] Decreased blood-brain barrier P-glycoprotein function with aging
    Bauer, Martin
    Karch, Rudolf
    Neumann, Friederike
    Abrahim, Aiman
    Kletter, Kurt
    Mueller, Markus
    Langer, Oliver
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [28] Modulation of p-glycoprotein transport function at the blood-brain barrier
    Bauer, B
    Hartz, AMS
    Fricker, G
    Miller, DS
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 230 (02) : 118 - 127
  • [29] Involvement of P-glycoprotein in an in vitro blood-brain barrier model
    Joly, B
    Lecureur, V
    Puozzo, C
    Guillouzo, A
    Fardel, O
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (05) : 1029 - 1033
  • [30] Inhibition of P-Glycoprotein Function by Procyanidine on Blood-Brain Barrier
    He, Ling
    Zhao, Chuan
    Yan, Ming
    Zhang, Lu-Yong
    Xia, Yuan-Zheng
    PHYTOTHERAPY RESEARCH, 2009, 23 (07) : 933 - 937